Family · Pharmaceutical analytical standards
3,5-Diiodo-L-thyronine 4'-O-beta-D-Glucuronide
A synthetic form of triiodothyronine (T3), one of the two hormones made by the thyroid, approved in 1956 to treat hypothyroidism and myxoedema coma. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.
Did you know?T3 was identified in the early 1950s in London by Jack Gross and Rosalind Pitt-Rivers: it is the most potent form of thyroid hormone, and the body makes it from thyroxine.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
